# Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality

> **NCT03036462** · PHASE4 · COMPLETED · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 1105 (actual)

## Conditions studied

- Systolic Heart Failure
- Iron Deficiency

## Interventions

- **DRUG:** Iron
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03036462
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-07
- **Primary completion:** 2024-05-02
- **Final completion:** 2024-05-02
- **Target enrollment:** 1105 (ACTUAL)
- **Last updated:** 2025-01-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03036462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03036462, "Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03036462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*